Strid Group’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.9M Buy
614,150
+86,127
+16% +$2.09M 1.85% 7
2025
Q4
$12.8M Buy
528,023
+92,538
+21% +$2.25M 1.6% 11
2025
Q3
$10.6M Buy
435,485
+601
+0.1% +$14.6K 1.35% 13
2025
Q2
$10.6M Buy
434,884
+93,405
+27% +$2.25M 1.48% 11
2025
Q1
$8.26M Buy
341,479
+142,378
+72% +$3.42M 1.28% 11
2024
Q4
$4.77M Buy
199,101
+62,556
+46% +$1.51M 0.74% 16
2024
Q3
$3.33M Sell
136,545
-23,150
-14% -$558K 0.51% 19
2024
Q2
$3.79M Buy
159,695
+87,365
+121% +$2.07M 0.63% 16
2024
Q1
$1.72M Buy
72,330
+54,409
+304% +$1.3M 0.31% 20
2023
Q4
$429K Buy
+17,921
New +$418K 0.09% 38

Other funds holding IBDS

Strid Group's IBDS Position: Q1 2026 in Review

Strid Group increased its iShares iBonds Dec 2027 Term Corporate ETF (IBDS) stake by 16% in Q1 2026, buying an estimated $2.09M and bringing the position to 614,150 shares worth $14.9M. The position accounts for 1.85% of the portfolio, ranked #7.

Strid Group first reported a position in IBDS in Q4 2023 and has held it in 10 quarters since. 428 funds tracked by Wall St. Rank hold IBDS as of Q1 2026.

  • Strid Group held 614,150 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $14.9M as of Q1 2026.
  • Strid Group bought 86,127 iShares iBonds Dec 2027 Term Corporate ETF shares in Q1 2026, an estimated $2.09M.
  • iShares iBonds Dec 2027 Term Corporate ETF made up 1.85% of Strid Group's portfolio in Q1 2026, its #7 holding.
  • Strid Group first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q4 2023 and has held it in 10 quarters since.
  • 428 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q1 2026.

Based on Strid Group's 13F filing for Q1 2026, filed 29 Apr 2026.